Certified by Founder Lodge
EcoR1 Capital, LLC
United States - San Francisco Bay Area
INVESTOR
1 Disclosed Funding Rounds $50,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
EcoR1 Capital, LLC is a biotech focused investment advisory firm.
| Company | Date | Round | Raised |
|---|---|---|---|
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
adaptive(US) | $7,000,000 | (Apr 23, 2025)
Recce | $4,000,000 | (Apr 23, 2025)
Tally(US) | $8,000,000 | (Apr 23, 2025)
UbiQD, Inc. | $20,000,000 | (Apr 23, 2025)
GreenFi | $17,000,000 | (Apr 23, 2025)
